Expanding Indications for a Ketogenic Diet as an Adjuvant Therapy in Adult Refractory Status Epilepticus: an Exploratory Study Using Moderation Analysis
- PMID: 35974294
- PMCID: PMC9606186
- DOI: 10.1007/s13311-022-01282-z
Expanding Indications for a Ketogenic Diet as an Adjuvant Therapy in Adult Refractory Status Epilepticus: an Exploratory Study Using Moderation Analysis
Abstract
Refractory status epilepticus (RSE) requires multimodal treatment approaches to achieve rapid seizure cessation and neuroprotection. A ketogenic diet (KD) has demonstrated efficacy as a nutritional therapeutic option for adult RSE. However, the group of adult RSE patients who would benefit from adopting a KD needs to be determined to appropriately select the patients indicated for a KD. Therefore, we conducted a nonrandomized retrospective cohort study to explore the therapeutic efficacy of a KD by investigating the moderation effect of a KD on the association between the clinical characteristics of RSE patients and their functional outcomes. This study investigated 140 RSE patients, including 32 patients treated with a KD; among these patients, 28 (81%) achieved seizure cessation. We found that KD moderated the reduction in the modified Rankin scale (mRS) score at discharge among patients who were older, had higher seizure severity scores, were under continuous intravenous anesthetic therapy (CIVAD), and had super-RSE. Age and seizure severity scores, but not CIVAD or super-RSE, were associated with a KD-moderated change in mRS score at 3 months. Thus, we consider that our study provides evidence of a neuroprotective effect of KD in the most severe RSE patients with very few remaining therapeutic options, but future randomized controlled trials in these subgroups of KD patients are necessary.
Keywords: Ketogenic diet; Moderation analysis; Neuroprotection; Nutritional therapy; Refractory status epilepticus.
© 2022. The American Society for Experimental Neurotherapeutics, Inc.
Figures


Similar articles
-
Impact of timing of continuous intravenous anesthetic drug treatment on outcome in refractory status epilepticus.Crit Care. 2018 Nov 21;22(1):317. doi: 10.1186/s13054-018-2235-2. Crit Care. 2018. PMID: 30463604 Free PMC article.
-
Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus.Epilepsy Res. 2018 Aug;144:1-6. doi: 10.1016/j.eplepsyres.2018.04.012. Epub 2018 Apr 27. Epilepsy Res. 2018. PMID: 29727818
-
The Feasibility, Safety and Effectiveness of a Ketogenic Diet for Refractory Status Epilepticus in Adults in the Intensive Care Unit.Neurocrit Care. 2019 Jun;30(3):652-657. doi: 10.1007/s12028-018-0653-2. Neurocrit Care. 2019. PMID: 30484010
-
Treatment of Refractory Status Epilepticus With Continuous Intravenous Anesthetic Drugs: A Systematic Review.JAMA Neurol. 2024 May 1;81(5):534-548. doi: 10.1001/jamaneurol.2024.0108. JAMA Neurol. 2024. PMID: 38466294
-
Ketogenic diet in 3 cases of childhood refractory status epilepticus.Eur J Paediatr Neurol. 2013 Nov;17(6):531-6. doi: 10.1016/j.ejpn.2013.05.001. Epub 2013 Jun 14. Eur J Paediatr Neurol. 2013. PMID: 23751291 Review.
Cited by
-
Ketogenic diet for super-refractory status epilepticus (SRSE) with NORSE and FIRES: Single tertiary center experience and literature data.Front Neurol. 2023 Apr 13;14:1134827. doi: 10.3389/fneur.2023.1134827. eCollection 2023. Front Neurol. 2023. PMID: 37122314 Free PMC article.
-
Ketogenic diet for epilepsy control and enhancement in adaptive behavior.Sci Rep. 2023 Feb 6;13(1):2102. doi: 10.1038/s41598-023-27373-1. Sci Rep. 2023. PMID: 36747012 Free PMC article.
-
Nutritional Ketosis as a Therapeutic Approach in Critical Illness: A Systematic Review.Cureus. 2024 Jul 26;16(7):e65455. doi: 10.7759/cureus.65455. eCollection 2024 Jul. Cureus. 2024. PMID: 39071067 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources